Wuhan Keqian Biology Co.,Ltd (SHA:688526)
16.02
+0.43 (2.76%)
At close: Mar 6, 2026
SHA:688526 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 543.48 | 581.74 | 456.07 | 555.36 |
Short-Term Investments | - | 671.76 | 451.14 | 810 | 547.35 |
Trading Asset Securities | - | 719.51 | 745.04 | 674.83 | 212.95 |
Cash & Short-Term Investments | 1,721 | 1,935 | 1,778 | 1,941 | 1,316 |
Cash Growth | -11.02% | 8.82% | -8.40% | 47.52% | -39.76% |
Accounts Receivable | - | 354.81 | 343.15 | 406.52 | 294.4 |
Other Receivables | - | 55.06 | 37.47 | 34.96 | 32.02 |
Receivables | - | 409.88 | 635.68 | 441.48 | 326.42 |
Inventory | - | 125.6 | 144.8 | 169.4 | 108.82 |
Other Current Assets | - | 2.86 | 7.69 | 9.12 | 10.42 |
Total Current Assets | - | 2,473 | 2,566 | 2,561 | 1,761 |
Property, Plant & Equipment | - | 887.05 | 858.9 | 905.38 | 904.15 |
Long-Term Investments | - | 1,029 | 1,136 | 799.2 | 940.15 |
Goodwill | - | - | 3.31 | 3.31 | - |
Other Intangible Assets | - | 65.1 | 60.03 | 59.91 | 57.24 |
Long-Term Deferred Tax Assets | - | 0.96 | 0.3 | 26.8 | 16.28 |
Long-Term Deferred Charges | - | 1.6 | 1.18 | - | - |
Other Long-Term Assets | - | 38.95 | 45.88 | 35.13 | 46.2 |
Total Assets | - | 4,496 | 4,671 | 4,391 | 3,725 |
Accounts Payable | - | 178.26 | 165.03 | 244.27 | 215.74 |
Accrued Expenses | - | 87.64 | 88.36 | 92.79 | 76.04 |
Short-Term Debt | - | - | 206.65 | 131.6 | 18.03 |
Current Portion of Long-Term Debt | - | - | 80.05 | - | 60.06 |
Current Portion of Leases | - | 1.35 | 1.06 | 0.65 | - |
Current Income Taxes Payable | - | 30.77 | 53.98 | 31.09 | 46.83 |
Current Unearned Revenue | - | 148.6 | 157.61 | 101.7 | 63.18 |
Other Current Liabilities | - | 16.87 | 5.51 | 21.74 | 12.35 |
Total Current Liabilities | - | 463.5 | 758.25 | 623.84 | 492.24 |
Long-Term Debt | - | - | - | 140.11 | - |
Long-Term Leases | - | 5.55 | 5.75 | 7.12 | - |
Long-Term Unearned Revenue | - | 66.04 | 56.62 | 61.72 | 47.5 |
Long-Term Deferred Tax Liabilities | - | 17.71 | 12.97 | 56.84 | 29.68 |
Other Long-Term Liabilities | - | - | - | 1.99 | 1.99 |
Total Liabilities | - | 552.8 | 833.59 | 891.63 | 571.41 |
Common Stock | - | 466.13 | 466.17 | 466.21 | 465.13 |
Additional Paid-In Capital | - | 1,140 | 1,141 | 1,135 | 1,115 |
Retained Earnings | - | 2,387 | 2,204 | 1,897 | 1,576 |
Treasury Stock | - | -34.77 | -0.57 | -1.12 | -1.86 |
Comprehensive Income & Other | - | -17.14 | 25.33 | - | - |
Total Common Equity | 4,172 | 3,941 | 3,836 | 3,497 | 3,153 |
Minority Interest | - | 2.05 | 2.03 | 2.07 | 0.44 |
Shareholders' Equity | 4,173 | 3,943 | 3,838 | 3,499 | 3,154 |
Total Liabilities & Equity | - | 4,496 | 4,671 | 4,391 | 3,725 |
Total Debt | 6.94 | 6.9 | 293.51 | 279.48 | 78.09 |
Net Cash (Debt) | 1,715 | 1,928 | 1,484 | 1,661 | 1,238 |
Net Cash Growth | -11.07% | 29.87% | -10.65% | 34.25% | -41.73% |
Net Cash Per Share | 3.71 | 4.13 | 3.19 | 3.57 | 2.67 |
Filing Date Shares Outstanding | 439.63 | 463.92 | 464.69 | 466.21 | 465.13 |
Total Common Shares Outstanding | 439.63 | 463.92 | 466.17 | 466.21 | 465.13 |
Working Capital | - | 2,010 | 1,808 | 1,937 | 1,269 |
Book Value Per Share | 8.84 | 8.49 | 8.23 | 7.50 | 6.78 |
Tangible Book Value | 4,106 | 3,876 | 3,772 | 3,434 | 3,096 |
Tangible Book Value Per Share | 8.71 | 8.35 | 8.09 | 7.37 | 6.66 |
Buildings | - | 291.93 | 277.02 | 270.37 | 237.39 |
Machinery | - | 974.9 | 954.6 | 942.59 | 511.38 |
Construction In Progress | - | 134.51 | 43.05 | 17 | 388.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.